Form D · Biotechnology

Nexstim Plc

Helsinki, H9 · CIK 0001628859

Offering snapshot reported Dec 22, 2014 · SEC filing

Reported sold
$3.75M
Indefinite offering
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 14, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 22, 2014Initial$3,748,304No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-230633

Source: Form D, filed Dec 22, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Casper Breum Director
Ken Charhut Director
Johan Christenson Director
Henri Hannula Executive
John Hardin Executive
Rainer Harjunpaa Executive
Janne Huhtala Executive
Tim Irish Director
Gustaf Jarnefelt Executive
Mikko Karvinen Executive
Rene Kuijten Director
Jarmo Laine Executive
Petriina Puolakka Executive
Olli Riikkala Director
Katya ` Smirnyagina Director
Juha Vapaavuori Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Elimaenkatu 9 B
Helsinki, H9, FIN-00510